Concepts (173)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptor, Cannabinoid, CB1 | 11 | 2019 | 40 | 2.150 |
Why?
|
| Endocannabinoids | 9 | 2022 | 38 | 1.380 |
Why?
|
| Arachidonic Acids | 6 | 2017 | 24 | 1.230 |
Why?
|
| Cannabinoids | 8 | 2022 | 54 | 1.220 |
Why?
|
| Ethanol | 4 | 2019 | 188 | 1.110 |
Why?
|
| Receptor, Cannabinoid, CB2 | 6 | 2018 | 33 | 0.940 |
Why?
|
| Polyunsaturated Alkamides | 5 | 2017 | 14 | 0.830 |
Why?
|
| Neurogenesis | 2 | 2018 | 55 | 0.730 |
Why?
|
| Receptors, Cannabinoid | 6 | 2022 | 26 | 0.710 |
Why?
|
| Matrix Metalloproteinases | 2 | 2009 | 44 | 0.650 |
Why?
|
| Zebrafish | 2 | 2019 | 118 | 0.540 |
Why?
|
| Signal Transduction | 9 | 2019 | 1802 | 0.530 |
Why?
|
| Hippocampus | 1 | 2018 | 546 | 0.500 |
Why?
|
| GTP-Binding Proteins | 2 | 2002 | 57 | 0.430 |
Why?
|
| Nervous System | 1 | 2012 | 29 | 0.420 |
Why?
|
| Piperidines | 5 | 2022 | 76 | 0.370 |
Why?
|
| Neovascularization, Physiologic | 2 | 2009 | 70 | 0.350 |
Why?
|
| Molecular Probes | 1 | 2009 | 23 | 0.350 |
Why?
|
| Animals | 20 | 2022 | 14307 | 0.340 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gi-Go | 2 | 2007 | 15 | 0.340 |
Why?
|
| Endothelial Cells | 3 | 2009 | 296 | 0.320 |
Why?
|
| Pyrazoles | 4 | 2018 | 80 | 0.320 |
Why?
|
| Nitric Oxide | 2 | 2007 | 287 | 0.300 |
Why?
|
| Cyclic AMP | 1 | 2006 | 125 | 0.280 |
Why?
|
| Receptors, Drug | 2 | 2002 | 56 | 0.270 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 2007 | 127 | 0.270 |
Why?
|
| tat Gene Products, Human Immunodeficiency Virus | 3 | 2022 | 52 | 0.270 |
Why?
|
| Lipopolysaccharides | 1 | 2006 | 200 | 0.260 |
Why?
|
| Antineoplastic Agents | 1 | 2012 | 756 | 0.260 |
Why?
|
| Stroke | 1 | 2007 | 274 | 0.240 |
Why?
|
| Glycerides | 2 | 2017 | 10 | 0.240 |
Why?
|
| Disease Models, Animal | 3 | 2019 | 1300 | 0.230 |
Why?
|
| Macrophages | 1 | 2006 | 431 | 0.220 |
Why?
|
| Muscle Relaxation | 1 | 2002 | 17 | 0.220 |
Why?
|
| Rats | 6 | 2018 | 3261 | 0.220 |
Why?
|
| Hedgehog Proteins | 1 | 2019 | 45 | 0.180 |
Why?
|
| Embryo, Nonmammalian | 1 | 2019 | 57 | 0.170 |
Why?
|
| Amidohydrolases | 2 | 2022 | 10 | 0.170 |
Why?
|
| Zebrafish Proteins | 1 | 2019 | 45 | 0.170 |
Why?
|
| AIDS Dementia Complex | 1 | 2019 | 107 | 0.160 |
Why?
|
| Carbamates | 1 | 2018 | 11 | 0.160 |
Why?
|
| Ki-67 Antigen | 1 | 2018 | 32 | 0.160 |
Why?
|
| Naphthalenes | 3 | 2007 | 37 | 0.160 |
Why?
|
| Benzoxazines | 3 | 2007 | 46 | 0.160 |
Why?
|
| Morpholines | 3 | 2007 | 65 | 0.160 |
Why?
|
| Enzyme Inhibitors | 3 | 2022 | 396 | 0.160 |
Why?
|
| Neuropeptides | 1 | 2018 | 57 | 0.160 |
Why?
|
| Drug Interactions | 1 | 2018 | 137 | 0.160 |
Why?
|
| Matrix Metalloproteinase 9 | 2 | 2015 | 88 | 0.150 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2018 | 84 | 0.150 |
Why?
|
| Caspase 3 | 1 | 2018 | 194 | 0.150 |
Why?
|
| Piperazines | 1 | 2018 | 109 | 0.150 |
Why?
|
| Mice | 8 | 2022 | 5668 | 0.150 |
Why?
|
| Cells, Cultured | 3 | 2017 | 1442 | 0.150 |
Why?
|
| Pertussis Toxin | 3 | 2007 | 27 | 0.150 |
Why?
|
| Cell Death | 1 | 2018 | 260 | 0.150 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2019 | 283 | 0.150 |
Why?
|
| Neuroprotective Agents | 1 | 2017 | 231 | 0.130 |
Why?
|
| Spinal Cord Injuries | 1 | 2015 | 60 | 0.130 |
Why?
|
| Rabbits | 2 | 2007 | 278 | 0.130 |
Why?
|
| Endothelium, Vascular | 2 | 2009 | 229 | 0.120 |
Why?
|
| Up-Regulation | 3 | 2019 | 490 | 0.120 |
Why?
|
| Mice, Inbred C57BL | 4 | 2022 | 1530 | 0.120 |
Why?
|
| HIV-1 | 1 | 2019 | 678 | 0.120 |
Why?
|
| Carcinoma, Lewis Lung | 1 | 2013 | 6 | 0.120 |
Why?
|
| G-Protein-Coupled Receptor Kinases | 1 | 2013 | 7 | 0.120 |
Why?
|
| Arrestins | 1 | 2013 | 26 | 0.110 |
Why?
|
| Receptors, Interleukin-8B | 1 | 2013 | 20 | 0.110 |
Why?
|
| Monoacylglycerol Lipases | 1 | 2012 | 2 | 0.110 |
Why?
|
| Membrane Microdomains | 1 | 2012 | 46 | 0.110 |
Why?
|
| Cell Proliferation | 1 | 2018 | 1149 | 0.110 |
Why?
|
| Neutrophils | 1 | 2013 | 124 | 0.110 |
Why?
|
| Cyclooxygenase 2 | 1 | 2012 | 92 | 0.110 |
Why?
|
| Cysteine | 1 | 2012 | 88 | 0.100 |
Why?
|
| Motor Neurons | 1 | 2012 | 72 | 0.100 |
Why?
|
| Prosencephalon | 2 | 2012 | 25 | 0.100 |
Why?
|
| Neural Pathways | 1 | 2012 | 120 | 0.100 |
Why?
|
| Cyclohexanols | 2 | 2007 | 7 | 0.100 |
Why?
|
| Male | 5 | 2022 | 18870 | 0.090 |
Why?
|
| Neurons | 1 | 2017 | 1130 | 0.090 |
Why?
|
| Cell Line | 3 | 2012 | 1289 | 0.090 |
Why?
|
| Cell Membrane | 1 | 2012 | 360 | 0.090 |
Why?
|
| Azirines | 1 | 2009 | 2 | 0.090 |
Why?
|
| Photoaffinity Labels | 1 | 2009 | 3 | 0.090 |
Why?
|
| Azides | 1 | 2009 | 10 | 0.090 |
Why?
|
| Humans | 10 | 2012 | 34853 | 0.090 |
Why?
|
| Synaptic Transmission | 2 | 2022 | 141 | 0.090 |
Why?
|
| Mice, Transgenic | 2 | 2022 | 608 | 0.080 |
Why?
|
| Phosphorylation | 2 | 2013 | 878 | 0.080 |
Why?
|
| HIV Infections | 1 | 2022 | 2207 | 0.080 |
Why?
|
| Fluorescent Dyes | 1 | 2009 | 173 | 0.080 |
Why?
|
| Angiostatins | 1 | 2007 | 2 | 0.080 |
Why?
|
| Amino Acid Sequence | 3 | 2007 | 1124 | 0.080 |
Why?
|
| Mitochondrial Proton-Translocating ATPases | 1 | 2007 | 7 | 0.080 |
Why?
|
| Resorcinols | 1 | 2007 | 4 | 0.080 |
Why?
|
| Leucine | 1 | 2007 | 28 | 0.080 |
Why?
|
| Molecular Sequence Data | 3 | 2007 | 1490 | 0.080 |
Why?
|
| Benzofurans | 1 | 2007 | 19 | 0.080 |
Why?
|
| Guanylate Cyclase | 1 | 2007 | 17 | 0.080 |
Why?
|
| Cardiovascular Agents | 1 | 2007 | 20 | 0.080 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2006 | 20 | 0.070 |
Why?
|
| Cycloheximide | 1 | 2006 | 30 | 0.070 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2007 | 58 | 0.070 |
Why?
|
| Chromones | 1 | 2007 | 51 | 0.070 |
Why?
|
| Reactive Nitrogen Species | 1 | 2006 | 10 | 0.070 |
Why?
|
| Pregnancy | 1 | 2012 | 1503 | 0.070 |
Why?
|
| Brain Diseases | 1 | 2006 | 33 | 0.070 |
Why?
|
| Membrane Proteins | 2 | 2007 | 486 | 0.070 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2006 | 70 | 0.070 |
Why?
|
| Female | 5 | 2022 | 19873 | 0.070 |
Why?
|
| Antibodies, Monoclonal | 1 | 2007 | 282 | 0.070 |
Why?
|
| Carrier Proteins | 1 | 2007 | 287 | 0.070 |
Why?
|
| Brain Ischemia | 1 | 2007 | 179 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2007 | 245 | 0.070 |
Why?
|
| Microglia | 1 | 2006 | 152 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2007 | 984 | 0.060 |
Why?
|
| Reactive Oxygen Species | 1 | 2006 | 416 | 0.060 |
Why?
|
| Ligands | 1 | 2005 | 317 | 0.060 |
Why?
|
| Cell Line, Tumor | 2 | 2013 | 2128 | 0.060 |
Why?
|
| Models, Molecular | 2 | 2007 | 751 | 0.060 |
Why?
|
| Heterotrimeric GTP-Binding Proteins | 1 | 2002 | 10 | 0.060 |
Why?
|
| Receptors, Calcitonin Gene-Related Peptide | 1 | 2002 | 1 | 0.060 |
Why?
|
| Virulence Factors, Bordetella | 1 | 2002 | 7 | 0.060 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 2002 | 34 | 0.050 |
Why?
|
| Calcium Channels | 1 | 2002 | 72 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2002 | 122 | 0.050 |
Why?
|
| Capsaicin | 1 | 2002 | 23 | 0.050 |
Why?
|
| Gap Junctions | 1 | 2002 | 37 | 0.050 |
Why?
|
| Nitric Oxide Synthase | 1 | 2002 | 103 | 0.050 |
Why?
|
| Pyridines | 1 | 2022 | 113 | 0.050 |
Why?
|
| Aorta | 1 | 2002 | 161 | 0.050 |
Why?
|
| Cell Differentiation | 1 | 2002 | 562 | 0.040 |
Why?
|
| Psychomotor Performance | 1 | 2019 | 126 | 0.040 |
Why?
|
| Prefrontal Cortex | 1 | 2017 | 133 | 0.030 |
Why?
|
| Spinal Cord | 1 | 2015 | 85 | 0.030 |
Why?
|
| Calcium | 1 | 2017 | 445 | 0.030 |
Why?
|
| Cell Survival | 1 | 2017 | 818 | 0.030 |
Why?
|
| Phenylurea Compounds | 1 | 2013 | 18 | 0.030 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2013 | 47 | 0.030 |
Why?
|
| Chemotaxis | 1 | 2013 | 57 | 0.030 |
Why?
|
| Wound Healing | 1 | 2013 | 69 | 0.030 |
Why?
|
| Lipoylation | 1 | 2012 | 13 | 0.030 |
Why?
|
| Neovascularization, Pathologic | 1 | 2013 | 122 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2013 | 211 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 1 | 2012 | 200 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2013 | 420 | 0.020 |
Why?
|
| Genotype | 1 | 2013 | 641 | 0.020 |
Why?
|
| Disease Progression | 1 | 2013 | 580 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2013 | 897 | 0.020 |
Why?
|
| Lung Neoplasms | 1 | 2013 | 336 | 0.020 |
Why?
|
| Corneal Neovascularization | 1 | 2007 | 6 | 0.020 |
Why?
|
| Binding Sites, Antibody | 1 | 2007 | 19 | 0.020 |
Why?
|
| Chorioallantoic Membrane | 1 | 2007 | 10 | 0.020 |
Why?
|
| Mutation | 1 | 2012 | 1023 | 0.020 |
Why?
|
| Epitope Mapping | 1 | 2007 | 31 | 0.020 |
Why?
|
| Mutagenesis | 1 | 2007 | 87 | 0.020 |
Why?
|
| Biomimetic Materials | 1 | 2007 | 23 | 0.020 |
Why?
|
| Catalytic Domain | 1 | 2007 | 97 | 0.020 |
Why?
|
| Analgesics | 1 | 2007 | 56 | 0.020 |
Why?
|
| Protein Structure, Secondary | 1 | 2007 | 172 | 0.020 |
Why?
|
| Rats, Inbred F344 | 1 | 2007 | 228 | 0.020 |
Why?
|
| Vascular Diseases | 1 | 2007 | 30 | 0.020 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2007 | 109 | 0.020 |
Why?
|
| Lipid Bilayers | 1 | 2007 | 66 | 0.020 |
Why?
|
| Adenosine Triphosphate | 1 | 2007 | 180 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2007 | 383 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2007 | 342 | 0.020 |
Why?
|
| Cattle | 1 | 2007 | 472 | 0.020 |
Why?
|
| Drug Design | 1 | 2007 | 154 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2007 | 195 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2007 | 649 | 0.020 |
Why?
|
| Protein Binding | 1 | 2007 | 913 | 0.020 |
Why?
|
| Brain | 1 | 2006 | 1268 | 0.010 |
Why?
|